BCBS Units Sue Insys Over Off-Label Fentanyl Rx Scheme
Several Blue Cross Blue Shield Association units have accused Insys Therapeutics Inc. in Arizona federal court of bribing physicians to write off-label prescriptions for its Fentanyl spray, causing the insurers to...To view the full article, register now.
Already a subscriber? Click here to view full article